- Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
-
Hue H, Kim K, Kim H, Suh DH, No JH, Kim YB
- KMID: 2451659
- Obstet Gynecol Sci.
- 2019 Jul;62(4):285-289.
- doi: 10.5468/ogs.2019.62.4.285
The long-term survival of heavily pretreated patients with primary peritoneal cancer (PPC) is uncommon. Here, we report on a patient with PPC refractory to multiple lines of intravenous chemotherapy, namely,... -
- CITED
-
- Close
- SHARE
-
- Close
